Revelation Biosciences REVB Balance Sheet (2020-2026)

NASDAQ REVB
$1.09 -0.02 (-1.80%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
1.27M7.20M3.50M6.20M5.25M17.70M15.70M13.99M11.99M14.55M12.10M6.50M6.50M3.70M5.20M12.71M10.70M11.50M
Short-term Investments (Quarter)
0.30M0.02M
Cash & Current Investments (Quarter)
0.30M0.02M1.27M7.20M3.50M6.20M5.25M17.70M15.70M13.99M11.99M14.55M12.10M6.50M6.50M3.70M5.20M12.71M10.70M11.50M
Prepaid Assets (Quarter)
0.07M0.02M0.64M0.62M0.41M0.21M0.07M0.33M0.25M0.15M0.08M0.07M0.13M0.12M0.07M0.22M0.19M0.12M0.11M0.20M
Current Assets (Quarter)
0.37M0.04M1.91M7.87M4.05M6.51M5.41M18.04M15.96M14.15M12.15M14.62M12.20M6.66M6.57M3.93M5.36M12.83M10.81M11.68M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.12M0.11M0.10M0.10M0.09M0.08M0.08M0.07M0.07M0.08M0.07M0.08M0.06M0.04M0.04M0.02M0.02M0.17M
Long-Term Investments (Quarter)
73.51M73.52M48.30M
Long-Term Deferred Tax (Quarter)
0.82M
Other Non-Current Assets (Quarter)
0.03M0.03M
Non-Current Assets (Quarter)
73.51M73.52M0.13M0.11M0.10M0.10M0.09M0.08M0.08M0.07M0.07M0.08M0.07M0.08M0.06M0.04M0.04M0.02M0.77M0.81M
Assets (Quarter)
73.89M73.56M2.04M7.98M4.15M6.60M5.50M18.12M16.04M14.22M12.21M14.70M12.27M6.74M6.62M3.97M5.40M12.86M11.58M12.50M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.08M1.59M0.60M1.46M0.92M0.47M0.55M0.71M0.91M1.26M1.36M1.68M1.28M3.13M0.78M0.63M0.83M1.03M0.58M0.93M
Notes Payables (Quarter)
2.23M2.14M2.39M
Payables (Quarter)
3.31M3.74M2.99M1.46M0.92M0.47M0.55M0.71M0.91M1.26M1.36M1.68M1.28M3.13M0.78M0.63M0.83M1.03M0.58M0.93M
Accumulated Expenses (Quarter)
1.53M3.71M2.17M1.00M0.99M0.97M0.50M1.02M1.15M0.62M8.45M0.93M1.13M0.46M0.74M0.82M1.40M0.76M
Other Accumulated Expenses (Quarter)
0.14M1.28M1.54M
Current Leases (Quarter)
0.02M0.02M0.19M
Total Current Liabilities (Quarter)
3.31M3.74M2.14M8.08M6.00M4.37M4.45M8.10M4.62M5.40M5.56M5.23M11.13M4.07M1.91M1.09M1.57M1.85M2.00M1.88M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
2.91M2.91M2.91M2.91M2.91M2.91M2.91M2.91M2.91M2.91M2.91M2.91M1.38M
Preferred Stock Liabilities (Quarter)
73.51M73.51M47.81M
Operating Leases (Quarter)
0.72M0.55M
Other Non-Current Liabilities (Quarter)
1.01M3.51M0.30M0.21M0.14M0.02M0.01M0.00M0.00M829.00786.00175.00
Total Non-Current Liabilities (Quarter)
1.13M4.59M4.32M5.19M5.42M5.21M11.12M4.06M1.91M1.09M1.57M1.85M
Total Liabilities (Quarter)
6.22M6.65M2.14M8.08M6.00M4.37M4.45M8.10M4.62M5.40M5.56M5.23M11.13M4.07M1.91M1.09M1.57M1.85M2.72M2.43M
Shareholder's Equity
Common Equity (Quarter)
6.57M3.66M-0.10M-0.10M-1.84M2.23M1.05M10.02M11.41M8.82M6.65M9.47M1.14M2.67M4.71M2.88M3.83M11.00M8.90M10.10M
Liabilities and Shareholders Equity (Quarter)
73.89M73.56M2.04M7.98M4.15M6.60M5.50M18.12M16.04M14.22M12.21M14.70M12.27M6.74M6.62M3.97M5.40M12.86M11.58M12.50M
Retained Earnings (Quarter)
-5.85M-6.60M14.42M-21.13M-23.00M26.34M26.40M29.20M-20.60M-23.30M-25.47M-28.15M37.68M41.45M45.21M-42.60M48.83M-46.90M-49.42M65.81M
Treasury Shares (Quarter)
7.28M7.28M0.26M0.01M0.00M0.00M0.00M94.0094.0094.0094.000.25M0.23M